Brief: Vivimed Labs Gets Export Order For Supply Of Generic COVID-19 Drug Favipiravir
Aug 5 (Reuters) - Vivimed Labs Ltd VVMD.NS :
* VIVIMED LABS LTD SAYS RECEIPT OF EXPORT ORDER FOR SUPPLY
OF
'FAVULOUS' TABLETS 200 MG (FAVIPIRAVIR)
* VIVIMED LABS LTD SAYS INITIAL EXPORT ORDER VALUE IS WORTH
OVER
100 MILLION RUPEES
Source text for Eikon: ID:nBSEbkgHWR
Further company coverage: VVMD.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivimed Labs
See all newsBrief: Vivimed Labs Says Telangana High Court Grants Interim Stay On Proceedings
Brief: Vivimed Labs Ltd Phaninder Nath Resigns As CFO
Brief: Vivimed Labs CFO And CS Receive Notice From CBI
Brief: Vivimed Labs Says Got Notice From Debt Recovery Tribunal Regarding Application Filed By State Bank Of India
Brief: Vivimed Labs Names Ramakanta Tripathy As CFO